NEXIEN BIOPHARMA, INC. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$239.1K

Total Assets (FY2024)

$4.2K

Total Equity (FY2024)

-$361.2K

Cash Flows from Operating Activities (FY2024)

-$64.4K

Source: NEXIEN BIOPHARMA, INC. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.